CLINICAL_TRIALS
trial_result
· 2019-07-26
Clinical Trial Update: Phase I Biomarker Study (BMS-936558) [Phase 1]
Summary
Phase I biomarker study of BMS-936558 in renal cell carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Renal Cell Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2019-07-26